Insulin-loaded nanoparticles are prepared by alginate ionotropic pre-gelation followed by chitosan polyelectrolyte complexation

被引:164
作者
Sarmento, B. [1 ]
Ribeiro, A. J.
Veiga, F.
Ferreira, D. C.
Neufeld, R. J.
机构
[1] Univ Porto, Fac Pharm, Dept Pharmaceut Technol, P-4100 Oporto, Portugal
[2] ISCSN, Dept Pharmaceut Technol, Gandra, Portugal
[3] Univ Coimbra, Fac Pharm, Dept Pharmaceut Technol, Coimbra, Portugal
[4] Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada
关键词
alginate; chitosan; insulin; nanoparticles; particle size; pre-gelation;
D O I
10.1166/jnn.2007.609
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Alginate nanoparticles were prepared from dilute alginate sol by inducing a pre-gel with calcium counter ions, followed by polyelectrolyte complex coating with chitosan. Particles in the nanometer size range were obtained with 0.05% alginate and 0.9 mM Ca2+. The mean particle size was influenced by time and stirring speed of nanoparticle preparation, by alginate guluronic acid content and chitosan molecular weight and by the initial alginate:chitosan mass ratio. The association efficiency of insulin into alginate nanoparticles, as well as loading capacity were mainly influenced by the alginate:chitosan mass ratio. Under optimized size conditions, the association efficiency and loading capacities were as high as 92% and 14.3%, respectively. Approximately 50% of the protein was partially retained by the nanoparticles in gastric pH environment up to 24 hours while a more extensive release close to 75% was observed under intestinal pH conditions. Mild formulation conditions, optimum particle size range obtained, high insulin entrapment efficiency, and resistance to gastrointestinal release seem to be synergic and promising factors toward development of an oral insulin delivery form.
引用
收藏
页码:2833 / 2841
页数:9
相关论文
共 37 条
[11]   Enhancement of nasal absorption of insulin using chitosan nanoparticles [J].
Fernández-Urrusuno, R ;
Calvo, P ;
Remuñán-López, C ;
Vila-Jato, JL ;
Alonso, MJ .
PHARMACEUTICAL RESEARCH, 1999, 16 (10) :1576-1581
[12]   Characterization of alginate/poly-L-lysine particles as antisense oligonucleotide carriers [J].
Ferreiro, MG ;
Tillman, L ;
Hardee, G ;
Bodmeier, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 239 (1-2) :47-59
[13]   Protein release from alginate matrices [J].
Gombotz, WR ;
Wee, SF .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 31 (03) :267-285
[14]   BIOLOGICAL INTERACTIONS BETWEEN POLYSACCHARIDES AND DIVALENT CATIONS - EGG-BOX MODEL [J].
GRANT, GT ;
MORRIS, ER ;
REES, DA ;
SMITH, PJC ;
THOM, D .
FEBS LETTERS, 1973, 32 (01) :195-198
[15]  
HAUG A, 1964, THESIS TRONDHEIM NOR
[16]   Chitosan-based gastrointestinal delivery systems [J].
Hejazi, R ;
Amiji, M .
JOURNAL OF CONTROLLED RELEASE, 2003, 89 (02) :151-165
[17]   Stability of insulin during the erosion of poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres [J].
Ibrahim, MA ;
Ismail, A ;
Fetouh, MI ;
Göpferich, A .
JOURNAL OF CONTROLLED RELEASE, 2005, 106 (03) :241-252
[18]  
Illum L, 1998, PHARM RES-DORDR, V15, P1326
[19]   Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? [J].
Jung, T ;
Kamm, W ;
Breitenbach, A ;
Kaiserling, E ;
Xiao, JX ;
Kissel, T .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) :147-160
[20]   Swelling behaviour of alginate-chitosan microcapsules prepared by external gelation or internal gelation technology [J].
Liu, XD ;
Xue, WM ;
Liu, Q ;
Yu, WT ;
Fu, YL ;
Xiong, X ;
Ma, XJ ;
Yuan, Q .
CARBOHYDRATE POLYMERS, 2004, 56 (04) :459-464